the-201

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namethe-201
Drug Alias Nametumor-targeting bacteria-delivered actin inhibitor (Thelial)the-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActin inhibitors
TargetsActin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugal
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThelial Technologies SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThelial Technologies SA
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A